
Pfizer lowers COVID-19 vaccine doses for younger kids in clinical trial
Fox News
Pfizer said it has selected lower dosages of its COVID-19 vaccine for Phase 2/3 portions of its clinical trial involving kids younger than 11 than the volume given to shot recipients ages 12 and older.
A spokesperson told Fox News in a statement that the lower dosages were determined "based on the safety, tolerability and immunogenicity from our Phase 1 study."More Related News

Pizza before tomatoes? Ancient Rome's version of America's favorite food looked nothing like today's
Ancient Rome pizza at Hungary restaurant features no tomatoes or mozzarella, using garum fish sauce and olive paste. Neverland Pizzeria's dish is limited-edition.












